(Q38369816)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748625%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

review article

1 reference

title

GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748625%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748625%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

John A Hamilton

series ordinal

1

1 reference

2 September 2017

8 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748625%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Clinical Immunology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748625%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748625%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748625%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

457-465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748625%20AND%20SRC:MED&resulttype=core&format=json

GM-CSF in inflammation and autoimmunity.

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Functions of granulocyte-macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Colony-stimulating factors in inflammation and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Colony stimulating factors and myeloid cell biology in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF as a therapeutic target in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Effect of haematopoietic cell growth factor on intracellular ATP levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Origin of the lamina propria dendritic cell network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF increases cross-presentation and CD103 expression by mouse CD8⁺ spleen dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Systematic cytokine receptor profiling reveals GM-CSF as a novel TLR-independent activator of human plasmacytoid predendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Juvenile Myelomonocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF action in the CNS decreases food intake and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Tumor-derived GM-CSF promotes inflammatory colon carcinogenesis via stimulating epithelial release of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF-responsive monocyte-derived dendritic cells are pivotal in Th17 pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Macrophage activation and polarization: nomenclature and experimental guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Macrophage lineage phenotypes and osteoclastogenesis—Complexity in the control by GM-CSF and TGF-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Innate response activator B cells protect against microbial sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF is not essential for optimal fertility or for weight control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

The role of GM-CSF in adipose tissue inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Transgenic expression of GM-CSF in T cells causes disseminated histiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

A GM-CSF/IL-33 pathway facilitates allergic airway responses to sub-threshold house dust mite exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF: a role in immune and inflammatory reactions in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Sargramostim (GM-CSF) for induction of remission in Crohn's disease: a cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Granulocyte-macrophage colony-stimulating factor (GM-CSF): a chemoattractive agent for murine leukocytes in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

Differentiation of Inflammatory Dendritic Cells Is Mediated by NF- B1-Dependent GM-CSF Production in CD4 T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1024110

10.1586/1744666X.2015.1024110

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748625%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference